Ribavirin and quercetin synergistically downregulate signal transduction and are cytotoxic in human ovarian carcinoma cells

Oncology Research

Volumn 11, Issue 5, 1999, Pages 243-247

  Li, W ^a   Shen, F ^a   Weber, G ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Cell cycle; Cytotoxicity; Human myeloma 8226 cells; Human ovarian carcinoma ovcar 5 cells; IMP DH; IP3; Quercetin; Ribavirin; Signal transduction

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; QUERCETIN; RIBAVIRIN;

ARTICLE; CELL CULTURE; CELL CYCLE; DOSE RESPONSE; DOWN REGULATION; DRUG COMBINATION; DRUG EFFECT; DRUG POTENTIATION; FEMALE; HUMAN; MULTIPLE MYELOMA; OVARY TUMOR; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; CELL CYCLE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MULTIPLE MYELOMA; OVARIAN NEOPLASMS; QUERCETIN; RIBAVIRIN; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0033258269     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. McHutchison, J. G.; Gordon, S. C.; Shiff, E. R.; Shiffman, M. L.; Lee, W. M.; Rustug, V. K.; Goodman, Z. D.; Ling, M. -H.; Cort, S.; Albrecht, J. K. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N. Engl. J. Med. 339:1485-1492; 1998.
2. Davis, G. L.; Esteban-Mur, R.; Rutgi, V.; Hoefs, J.; Gordon, S. C.; Trepo, C.; Shiffman, M. L.; Zeuzem, S.; Craxi, A.; Ling, M.-H.; Albrecht, J. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N. Engl. J. Med. 339:1493-1499; 1998.
3. Bodenheimer, H. C., Jr.; Lindsay, K. L.; Davis, G. L.; Lewis, J. H.; Thung, S. N.; Seeff, L. B. Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: A multicenter trial. Hepatology 26:473-477; 1997.
4. Prajda, N.; Hata, Y.; Abonyi, M.; Singhal, R. L.; Weber, G. Sequential impact of tiazorurin and ribavirin on the enzymic program of the bone marrow. Cancer Res. 53:5982-5986; 1993.
5. Yamada, Y.; Nalsumeda, Y.; Weber, G. Action of the active metabolites of tiazofurin and ribavirin on purfied IMP dehydrogenase. Biochemistry 27:2193-2196; 1988.
6. Yamada, Y.; Goto, H.; Yoshino, M.; Ogasawara, N. IMP dehydrogenase and action of antimetabolites in human cultured blast cells. Biochim. Biophys. Acta 1051:209-214; 1990.
7. Patterson, J. L.; Fernandez-Larsson, R. Molecular mechanism of action of ribavirin. Rev. Infect. Dis. 12:1139-1146; 1990.
8. Weber, G.; Shen, F.; Prajda, N.; Yang, H.; Li, W.; Csokay, B.; Olah, E.; Look, K. Y. Regulation of the signal transduction program by drugs. Adv. Enzyme Regul. 37:35-55; 1997.
9. Ilyin, G. P.; Langouet, S.; Rissel, M.; Delcros, J.-G.; Guillouzo, A.; Guauen-Guillouzo, C. Ribavirin inhibits protein synthesis and cell proliferation induced by mitogenic factors in primary human and rat hepatocytes. Hepatology 27:1687-1694; 1998.
10. Nishioka, N.; Imoro, M.; Sawa, T.; Hamada, M.; Naganawa, H.; Takeuchi, T.; Umezawa, K. Screening of phosphatidylinositol kinase inhibitors from Streptomyces. J. Antibiot. 42:823-825; 1989.
11. Prajda, N.; Singhal, R. L.; Yeh, Y. A.; Olah, E.; Look, K. Y.; Weber, G. Linkage of reduction in 1-phosphatidylinositol 4-kinase activity and inositol 1,4,5-trisphosphate concentration in human ovarian carcinoma cells treated with quercetin. Life Sci. 56:1587-1593; 1995.
12. Shen, F.; Weber, G. Synergistic action of quercetin and genistein in human ovarian carcinoma cells. Oncol. Res. 9:597-602; 1997.
13. Yoshida, M.; Sakai, T.; Hosokawa, N.; Marui, N.; Natsumoto, K.; Kujioka, A.; Nishino, H.; Aoike, A. The effect of quercetin on cell cycle progression and growth of human gastric cancer cells. FEBS Lett. 260:10-13; 1990.
14. Hosokawa, N.; Hosokawa, Y.; Sakai, T.; Yoshida, M.; Marui, N.; Nishino, H.; Kawai, K.; Aoike, A. Inhibitory effect of quercetin on synthesis of a possibly cell-cycle-related 17-KDA protein, in human colon cancer cells. Int. J. Cancer 45:1119-1124; 1990.
15. Singhal, R. L.; Yeh, Y. A.; Look, K. Y.; Sledge, G. W. Jr.; Weber, G. Coordinated increase in activities of the signal transduction enzymes PI kinase and PIP kinase in human cancer cells. Life Sci. 55:1487-1492; 1994.
16. Weber, G.; Shen, F.; Prajda, N.; Yang, H.; Li, W.; Yeh, A.; Csokay, B.; Olah, E.; Look, K. Y. Regulation of the signal transduction program by drugs. Adv. Enzyme Regul. 37:35-55; 1997.
17. Chou, T. C.; Talalay, P. Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 22:27-55; 1984.
18. Webb, J. L. Enzyme and metabolic inhibitors, vol. 1. New York: Academic Press; 1963:507-510.